Home/Filings/4/0001358403-19-000112
4//SEC Filing

Naeve Gregory S. 4

Accession 0001358403-19-000112

CIK 0001358403other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 4:04 PM ET

Size

5.3 KB

Accession

0001358403-19-000112

Insider Transaction Report

Form 4
Period: 2019-08-21
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
  • Tax Payment

    Common Stock

    2019-08-21$0.95/sh1,597$1,51313,746 total
Footnotes (2)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on August 21, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on August 21, 2017 for 15,000 shares, of which 3,750 vested on August 21, 2019. The RSUs vest in four equal annual installments beginning August 21, 2018.
  • [F2]Includes 902 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on June 10, 2019.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeother

Related Parties

1
  • filerCIK 0001714833

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:04 PM ET
Size
5.3 KB